The DOI matches its Crossref record; 0 of the 2 references it cites were found in a registry or an index.
A RATING SCALE FOR DEPRESSION
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mothers were deemed eligible if they had a current diagnosis of major depressive disorder according to DSM-IV criteria, received a score ≥ 15 on the Hamilton Rating Scale for Depression (HAM-D 25-item version)[33] and were the custodial parent of a 7–18-year-old child receiving psychiatric treatment for an internalizing disorder.”
From ROLE OF MATERNAL CHILDHOOD TRAUMA ON PARENTING AMONG DEPRESSED MOTHERS OF PSYCHIATRICALLY ILL CHILDREN: Research Article: Maternal Depression and Childhood Trauma (2013) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While each of these instruments is well-validated for assessing overall suicide risk, none were developed to assess short-term changes in SI.”
From New methods for assessing rapid changes in suicide risk (2021) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The HDRS-17 (33), one of the methods most commonly employed to measures change in depressive symptoms severity in treatment for depression clinical trials, was derived from the HDRS-28, and used as dependent variable.”
From Monitoring Changes in Depression Severity Using Wearable and Mobile Sensors (2020) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is in accordance with Aaron Beck's famous contention that depression is not only manifested in a negative self-appraisal but also involves negative cognitions about the world and the future.”
From The more it is needed, the less it is wanted: Attitudes toward face-to-face intervention among depressed patients undergoing online treatment (2013) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“greater depression severity, as assessed by the Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960), was an independent predictor of TSST-induced increases in both IL-6 and NFκ B while adjusting for the effects of early life stress on inflammatory activity”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Hamilton, 1960
The cited source says what the claim attributes to it.
In the citing paper
“The Hamilton Rating Scales for Anxiety (HAM‐A) (Hamilton, 1959) and Depression (HAM‐D, 17‐item version) (Hamilton, 1960) were used to quantify the degree of anxiety and depression, respectively.”
From Differences in response inhibition between medication-free patients with obsessive-compulsive disorder with and without sensory phenomena (2026) · cites this paper as Hamilton, 1960
The cited source says what the claim attributes to it.
In the citing paper
“The HAM-D consists of 21 items but is scored on the first 17 items.”
The cited source says what the claim attributes to it.
In the citing paper
“The higher the score, the greater the severity of depressive symptoms.”
The cited source says what the claim attributes to it.
In the citing paper
“The HAM-D is an observer-administered instrument to assess the severity of depressive symptoms.”
The cited source says what the claim attributes to it.
In the citing paper
“Studies with psychiatric samples show substantial correlation coefficients for BDI and the Hamilton Depression Rating Scale (HDRS; [23] ) ranging from r = .61 to .81; the mean correlation coefficient is r = .73. [22] Internal consistency for both psychiatric and nonpsychiatric populations is above .8. [24]”
From The more it is needed, the less it is wanted: Attitudes toward face-to-face intervention among depressed patients undergoing online treatment (2013) · cites this paper as [24]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The interpretation of the total score is such that the score of 0–7 indicates normal, 8–16 denotes mild depression, 17–23 indicates moderate depression, and 24 and above denotes severe depression (42).”
From The efficacy of virtual reality exposure therapy for the treatment of alcohol use disorder among adult males: a randomized controlled trial comparing with acceptance and commitment therapy and treatment as usual (2023) · cites this paper as [42]
Experimental — accuracy not yet measuredIn the citing paper
“While each of these instruments is well-validated for assessing overall suicide risk, none were developed to assess short-term changes in SI.”
From New methods for assessing rapid changes in suicide risk (2021) · cites this paper as [24]
In the citing paper
“For example, most of the literature exploring the anti-suicidal effects of ketamine used single items from the Montgomery-Åsberg Depression Rating Scale (MADRS; specifically, Item 10) (23) and the Hamilton Depression Rating Scale (HAM-D; specifically, Item 3) (24) as well as longer, suicide-specific measures such as the Scale for Suicide Ideation (SSI) (25) and the Columbia Suicide Severity Rating”
From New methods for assessing rapid changes in suicide risk (2021) · cites this paper as [24]
In the citing paper
“The symptomatic severity of BD was evaluated with the 17-item Hamilton Depression Scale (HAMD-17) (26) and the Young Mania Rating Scale (YMRS) (27). To make sure the quality and reliability of the assessment, it was performed by the same well-trained researcher (Zhaoyu Gan) on all the cases.”
From Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder? (2023) · cites this paper as [26]
In the citing paper
“Studies suggest that tobacco smokers have higher β2*-nAChR availability compared with non-smokers in non-psychiatric populations (34) which normalizes by 6–12 weeks of abstinence (44).”
From Persistent β 2 *-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder (2012) · cites this paper as [34]
In the citing paper
“In addition, the severity of depressive symptoms was assessed with the Hamilton Depression Rating Scale (HAMD) [26].”
From Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder (2013) · cites this paper as [26]
In the citing paper
“several symptom scales were developed for use within clinical samples only and may vary minimally in undiagnosed participants [12], [13]”
From How to boost positive interpretations? A Meta-Analysis of the effectiveness of cognitive bias modification for interpretation (2014) · cites this paper as [13]
In the citing paper
“several symptom scales were developed for use within clinical samples only and may vary minimally in undiagnosed participants [12], [13]”
From How to boost positive interpretations? A Meta-Analysis of the effectiveness of cognitive bias modification for interpretation (2014) · cites this paper as [13]
In the citing paper
“We chose daily evening administration to model the normal circadian variation in endogenous leptin, which is characterized by a pulsatile circadian rhythm with marked nocturnal rise (19).”
From Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults (2004) · cites this paper as [19]
In the citing paper
“Baseline depression severity [Hamilton Depression Rating Scale, HAMD (92)] predicted EMA-assessed sad mood and negative thoughts (incl. suicidal ideation) (81).”
From Don't Miss the Moment: A Systematic Review of Ecological Momentary Assessment in Suicide Research (2022) · cites this paper as [92]
In the citing paper
“the degree of depression was established using the Hamilton Depression Rating Scale (HDRS) (Table 1) [12].”
From Home-based psychiatric outpatient care through videoconferencing for depression: a randomized controlled follow-up trial (2016) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M., and White, J. (1959). J. ment. Sci., 105, 955.
Hamilton, M. ;. W. (1959) · J. ment. Sci
UnresolvedUnpublished data
Hamilton, M. ;. W. (1960)
Unresolved
Cited by
Sorted by citations
Items 2,001–2,100 of 3,053
Psychological interventions for patients with rheumatic diseases and anxiety or depression
Geenen, R., Newman, S., Bossema, E. R., Vriezekolk, J. E., & Boelen, P. A. (2012) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2012.05.004 · Cited by 94
Dunn, B. D., German, R. E., Khazanov, G., Xu, C., Hollon, S. D., & DeRubeis, R. J. (2020) · Clinical Psychological Science · doi:10.1177/2167702619863427 · Cited by 92
“Depression severity was measured using the 17-item HDRS (Hamilton, 1960), a clinician-administered interview that is frequently seen as the “gold standard” outcome measure in depression clinical trials.”
MethodInfluentialMood improvement reduces memory complaints in depressed patients
Antikainen, R., Hänninen, T., Honkalampi, K., Hintikka, J., Koivumaa-Honkanen, H., Tanskanen, A., & Viinamäki, H. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170060 · Cited by 93
Strous, R. D., Maayan, R., Lapidus, R., Goredetsky, L., Zeldich, E., Kotler, M., & Weizman, A. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.005 · Cited by 92
Romera, I., Perez, V., Menchón, J. M., Delgado-Cohen, H., Polavieja, P., & Gilaberte, I. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2009.02.007 · Cited by 91
Craske, M. G., Street, L., & Barlow, D. H. (1989) · Behaviour Research and Therapy · doi:10.1016/0005-7967(89)90150-2 · Cited by 89
Wichers, M., Lothmann, C., Simons, C. J. P., Nicolson, N. A., & Peeters, F. (2012) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.2011.02021.x · Cited by 89
Maina, G., Albert, U., Bellodi, L., Colombo, C., Faravelli, C., Monteleone, P., Bogetto, F., Cassano, G. B., & Maj, M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0205 · Cited by 92
Scott, F., Hampsey, E., Gnanapragasam, S., Carter, B., Marwood, L., Taylor, R. W., Emre, C., Korotkova, L., Martín-Dombrowski, J., Cleare, A. J., et al. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811221104058 · Cited by 87
“MDD was defined using either validated rating scales (e.g. the Hamilton Rating Scale for Depression; Hamilton, 1960) or operationalised diagnostic criteria (e.g. the Diagnostic and Statistical Manual of Mental Disorders; American Psychiatric Association, 1994).”
MethodSeven Year Prognosis in Depression: Mortality and Readmission Risk in the Nottingham ECT Cohort
O'Leary, D. A., & Lee, A. S. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.4.423 · Cited by 92
Circadian rhythms and psychiatric profiles in young adults with unipolar depressive disorders
Robillard, R., Carpenter, J. S., Rogers, N. L., Fares, S., Grierson, A. B., Hermens, D. F., Naismith, S. L., Mullin, S. J., Feilds, K.-L., Glozier, N., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0255-y · Cited by 92
Antidepressants for people with both schizophrenia and depression
Whitehead, C., Moss, S., Cardno, A., Lewis, G., & Furtado, V. A. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002305 · Cited by 92
Ranjbar, E., Shams, J., Sabetkasaei, M., M-Shirazi, M., Rashidkhani, B., Mostafavi, A., Bornak, E., & Nasrollahzadeh, J. (2014) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000066 · Cited by 92
Deisenhammer, E. A., Kramer-Reinstadler, K., Liensberger, D., Kemmler, G., Hinterhuber, H., & Wolfgang Fleischhacker, W. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2003.09.007 · Cited by 92
Buhmann, C. B., Nordentoft, M., Ekstroem, M., Carlsson, J., & Mortensen, E. L. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.150961 · Cited by 92
Perahia, D. G., Gilaberte, I., Wang, F., Wiltse, C. G., Huckins, S. A., Clemens, J. W., Montgomery, S. A., Montejo, A. L., & Detke, M. J. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.4.346 · Cited by 94
Differences in the immune-inflammatory profiles of unipolar and bipolar depression
Brunoni, A. R., Supasitthumrong, T., Teixeira, A. L., Vieira, E. L., Gattaz, W. F., Benseñor, I. M., Lotufo, P. A., Lafer, B., Berk, M., Carvalho, A. F., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.10.037 · Cited by 94
Treatment of depression in low-income older adults
Areán, P. A., Gum, A., McCulloch, C. E., Bostrom, A., Gallagher-Thompson, D., & Thompson, L. (2005) · Psychology and Aging · doi:10.1037/0882-7974.20.4.601 · Cited by 90
Fossey, M. D., Lydiard, R. B., Ballenger, J. C., Laraia, M. T., Bissette, G., & Nemeroff, C. B. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00197-2 · Cited by 90
Respiratory sinus arrhythmia reactivity in current and remitted major depressive disorder
Bylsma, L. M., Salomon, K., Taylor-Clift, A., Morris, B. H., & Rottenberg, J. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000019 · Cited by 89
Childhood traumatic experiences of patients with bipolar disorder type I and type II
Janiri, D., Sani, G., Danese, E., Simonetti, A., Ambrosi, E., Angeletti, G., Erbuto, D., Caltagirone, C., Girardi, P., & Spalletta, G. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.055 · Cited by 92
Rotenberg, V. S., Indursky, P., Kayumov, L., Sirota, P., & Melamed, Y. (2000) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(00)00110-0 · Cited by 91
Self- and clinician-rated montgomery-asberg depression rating scale: evaluation in clinical practice
Bondolfi, G., Jermann, F., Rouget, B. W., Gex-Fabry, M., McQuillan, A., Dupont-Willemin, A., Aubry, J.-M., & Nguyen, C. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.037 · Cited by 90
Attachment-based family therapy: Theory, clinical model, outcomes, and process research
Diamond, G., Diamond, G. M., & Levy, S. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.005 · Cited by 91
Jelinek, L., Randjbar, S., Seifert, D., Kellner, M., & Moritz, S. (2009) · Journal of Abnormal Psychology · doi:10.1037/a0015633 · Cited by 91
Levin, F. R., Mariani, J., Brooks, D. J., Pavlicova, M., Nunes, E. V., Agosti, V., Bisaga, A., Sullivan, M. A., & Carpenter, K. M. (2013) · Addiction · doi:10.1111/add.12108 · Cited by 89
Franklin, M. E., Abramowitz, J. S., Bux, D. A., Zoellner, L. A., & Feeny, N. C. (2002) · Professional Psychology: Research and Practice · doi:10.1037/0735-7028.33.2.162 · Cited by 90
Narushima, K., Chan, K.-L., Kosier, J. T., & Robinson, R. G. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1157 · Cited by 90
“Engage” Therapy: Behavioral Activation and Improvement of Late-Life Major Depression
Alexopoulos, G. S., Raue, P. J., Gunning, F., Kiosses, D. N., Kanellopoulos, D., Pollari, C., Banerjee, S., & Arean, P. A. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.11.006 · Cited by 84
Agorastos, A., Boel, J. A., Heppner, P. S., Hager, T., Moeller-Bertram, T., Haji, U., Motazedi, A., Yanagi, M. A., Baker, D. G., & Stiedl, O. (2013) · Stress · doi:10.3109/10253890.2012.751369 · Cited by 88
Steffens, D. C., Welsh-Bohmer, K. A., Burke, J. R., Plassman, B. L., Beyer, J. L., Gersing, K. R., & Potter, G. G. (2004) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704269819 · Cited by 90
The co-occurrence of PTSD and dissociation: differentiating severe PTSD from dissociative-PTSD
Armour, C., Karstoft, K.-I., & Richardson, J. D. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0819-y · Cited by 90
Elevated alpha-amylase but not cortisol in generalized social anxiety disorder
van Veen, J. F., van Vliet, I. M., DeRijk, R. H., van Pelt, J., Mertens, B., & Zitman, F. G. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.07.004 · Cited by 88
The determinants and longitudinal course of post-stroke mild cognitive impairment
SACHDEV, P. S., CHEN, X., BRODATY, H., THOMPSON, C., ALTENDORF, A., & WEN, W. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709990579 · Cited by 90
Huang, T.-L., & Lin, F.-C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.09.010 · Cited by 90
Appetite and food preference in depression: effects of imipramine treatment
Fernstrom, M. H., Krowinski, R. L., & Kupfer, D. J. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90180-6 · Cited by 90
Visuospatial priming and stroop performance in patients with obsessive compulsive disorder
Hartston, H. J., & Swerdlow, N. R. (1999) · Neuropsychology · doi:10.1037/0894-4105.13.3.447 · Cited by 89
Empirically supported psychosocial interventions for bipolar disorder: Current state of the research
Salcedo, S., Gold, A. K., Sheikh, S., Marcus, P. H., Nierenberg, A. A., Deckersbach, T., & Sylvia, L. G. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.018 · Cited by 92
Pang, J., Tang, X., Li, H., Hu, Q., Cui, H., Zhang, L., Li, W., Zhu, Z., Wang, J., & Li, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00616 · Cited by 85
“The inclusion criteria for the patients were as follows: Hamilton Anxiety Rating Scale (HAMA) score ≥ 14 (51) and Hamilton Depression Rating Scale (HAMD) score ≤ 14 (52); aged 18–60 years; at least 9 years of education; and medication free for at least 2 weeks.”
Geschwind, N., Peeters, F., Huibers, M., van Os, J., & Wichers, M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.104851 · Cited by 89
Fitzgerald, P. B., Hoy, K. E., Herring, S. E., Clinton, A. M., Downey, G., & Daskalakis, Z. J. (2013) · Depression and Anxiety · doi:10.1002/da.22005 · Cited by 88
Chiesa, A., Castagner, V., Andrisano, C., Serretti, A., Mandelli, L., Porcelli, S., & Giommi, F. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.02.003 · Cited by 89
Mosiołek, A., Mosiołek, J., Jakima, S., Pięta, A., & Szulc, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153377 · Cited by 87
“The aim of the study was to assess how antidepressants affect the level of neurotrophic markers and whether they could be a predictor of response to antidepressants [49,50].”
Backgroundten Doesschate, M. C., Koeter, M. W. J., Bockting, C. L. H., & Schene, A. H. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.026 · Cited by 91
Mentalization‐based treatment and its evidence‐base status: A systematic literature review
Malda‐Castillo, J., Browne, C., & Perez‐Algorta, G. (2019) · Psychology and Psychotherapy: Theory, Research and Practice · doi:10.1111/papt.12195 · Cited by 89
Neurocognitive predictors of antidepressant clinical response
Bruder, G. E., Alvarenga, J. E., Alschuler, D., Abraham, K., Keilp, J. G., Hellerstein, D. J., Stewart, J. W., & McGrath, P. J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.057 · Cited by 89
Perez, N., Langlest, F., Mallet, L., De Pieri, M., Sentissi, O., Thorens, G., Seragnoli, F., Zullino, D., Kirschner, M., Kaiser, S., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.07.011 · Cited by 88
“In order to determine the near maximum effective dose of psilocybin needed to achieve a reduction of depressive symptoms, we considered the mean changes from each study by extracting the baseline and endpoint score (mean ± SD) of each study using the Hamilton Depression Rating Scale ( Hamilton, 1960 ), the Montgomery-…”
InfluentialJiang, Y., Shorey, S., Seah, B., Chan, W. X., Tam, W. W. S., & Wang, W. (2018) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2017.08.006 · Cited by 88
Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
Laje, G., Perlis, R. H., Rush, A. J., & McMahon, F. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1446 · Cited by 89
Controlled trial of d-cycloserine adjuvant therapy for treatment-resistant major depressive disorder
Heresco-Levy, U., Javitt, D. C., Gelfin, Y., Gorelik, E., Bar, M., Blanaru, M., & Kremer, I. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.03.004 · Cited by 89
Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients
Schramm, E., Schneider, D., Zobel, I., van Calker, D., Dykierek, P., Kech, S., Härter, M., & Berger, M. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.10.013 · Cited by 88
Neuropsychological deficits in past suicide attempters with varying levels of depression severity
Keilp, J. G., Beers, S. R., Burke, A. K., Melhem, N. M., Oquendo, M. A., Brent, D. A., & Mann, J. J. (2014) · Psychological Medicine · doi:10.1017/s0033291714000786 · Cited by 88
Mondolo, F., Jahanshahi, M., Granà, A., Biasutti, E., Cacciatori, E., & Di Benedetto, P. (2006) · Behavioural Neurology · doi:10.1155/2006/136945 · Cited by 88
Comorbidity of obsessive‐compulsive disorder in recovered inpatients with bipolar disorder
Krüger, S., Bräunig, P., & Cooke, R. G. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020111.x · Cited by 88
de Diego-Adeliño, J., Portella, M. J., Gómez-Ansón, B., López-Moruelo, O., Serra-Blasco, M., Vives, Y., Puigdemont, D., Pérez-Egea, R., Álvarez, E., & Pérez, V. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110185 · Cited by 86
Uncoupling of social zeitgebers and diurnal cortisol secretion in clinical depression
Stetler, C., Dickerson, S. S., & Miller, G. E. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.03.003 · Cited by 88
Diagnostic validity of assessment scales for depression in patients with schizophrenia
Kim, S.-W., Kim, S.-J., Yoon, B.-H., Kim, J.-M., Shin, I.-S., Hwang, M. Y., & Yoon, J.-S. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.10.002 · Cited by 88
Ma, S., Yang, J., Yang, B., Kang, L., Wang, P., Zhang, N., Wang, W., Zong, X., Wang, Y., Bai, H., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.747139 · Cited by 91
Bedics, J. D., Atkins, D. C., Harned, M. S., & Linehan, M. M. (2015) · Psychotherapy · doi:10.1037/a0038457 · Cited by 88
Telephone-Based Cognitive–Behavioral Therapy for Depression in Parkinson Disease
Dobkin, R. D., Menza, M., Allen, L. A., Tiu, J., Friedman, J., Bienfait, K. L., Gara, M. A., & Mark, M. H. (2011) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988711422529 · Cited by 88
Remission onset and relapse in depression
O’Leary, D., Costello, F., Gormley, N., & Webb, M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00086-5 · Cited by 87
Differential effects of cognitive therapy and pharmacotherapy on depressive symptoms
Rush, A. J., Kovacs, M., Beck, A. T., Weissenburger, J., & Hollon, S. D. (1981) · Journal of Affective Disorders · doi:10.1016/0165-0327(81)90024-0 · Cited by 86
Effects of illness duration and treatment resistance on grey matter abnormalities in majordepression
Serra-Blasco, M., Portella, M. J., Gómez-Ansón, B., de Diego-Adeliño, J., Vives-Gilabert, Y., Puigdemont, D., Granell, E., Santos, A., Álvarez, E., & Pérez, V. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.116228 · Cited by 87
Prevalence of depressive symptoms and predictors of treatment among U.S. adults from 2005 to 2010
Wittayanukorn, S., Qian, J., & Hansen, R. A. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.12.009 · Cited by 86
Endogenous concentrations of DHEA and DHEA-S Decrease with remission of depression in older adults
Fabian, T. J., Dew, M. A., Pollock, B. G., Reynolds, C. F., Mulsant, B. H., Butters, M. A., Zmuda, M. D., Linares, A. M., Trottini, M., & Kroboth, P. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01198-2 · Cited by 87
Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature
Di Nicola, M., De Risio, L., Battaglia, C., Camardese, G., Tedeschi, D., Mazza, M., Martinotti, G., Pozzi, G., Niolu, C., Di Giannantonio, M., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.004 · Cited by 87
Zarski, A.-C., Berking, M., Reis, D., Lehr, D., Buntrock, C., Schwarzer, R., & Ebert, D. D. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.8814 · Cited by 87
“The cutoff points of 10, 19, 27, and 35 of the HRSD24 indicate mild, moderate, severe, and very severe depression, respectively [50-52].”
BackgroundMeasurement of Depressive Rumination and Associated Constructs
Luminet, O. (2003) · Depressive Rumination · doi:10.1002/9780470713853.ch10 · Cited by 87
Clinical correlates of early-onset and late-onset poststroke generalized anxiety
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1174 · Cited by 87
Adherence to Depression Treatment in Primary Care: A Randomized Clinical Trial
Sirey, J. A., Banerjee, S., Marino, P., Bruce, M. L., Halkett, A., Turnwald, M., Chiang, C., Liles, B., Artis, A., Blow, F., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3047 · Cited by 87
Attention and cognition in patients with obsessive–compulsive disorder
DE GEUS, F., DENYS, D. A. J. P., SITSKOORN, M. M., & WESTENBERG, H. G. M. (2007) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2007.01609.x · Cited by 83
Adherence to continuation and maintenance antidepressant use in recurrent depression
ten Doesschate, M. C., Bockting, C. L. H., & Schene, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.011 · Cited by 86
Altered Serum Levels of TNF-α, IL-6, and IL-18 in Depressive Disorder Patients
Fan, N., Luo, Y., Ou, Y., & He, H. (2017) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2588 · Cited by 85
Rush, G., O’Donovan, A., Nagle, L., Conway, C., McCrohan, A., O’Farrelly, C., Lucey, J. V., & Malone, K. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.035 · Cited by 86
BDNF genetic variants and methylation: effects on cognition in major depressive disorder
Ferrer, A., Labad, J., Salvat-Pujol, N., Barrachina, M., Costas, J., Urretavizcaya, M., de Arriba-Arnau, A., Crespo, J. M., Soriano-Mas, C., Carracedo, Á., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0601-8 · Cited by 84
Circulating microRNAs as biomarkers for depression: Many candidates, few finalists
Yuan, H., Mischoulon, D., Fava, M., & Otto, M. W. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.058 · Cited by 86
Cognitive deficits are associated with functional impairment in severely depressed patients
Vaughn McCall, W., & Dunn, A. G. (2003) · Psychiatry Research · doi:10.1016/j.psychres.2003.09.003 · Cited by 86
Changes in daily life experience associated with clinical improvement in depression
Barge-Schaapveld, D. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00012-c · Cited by 84
Kong, L., Chen, K., Womer, F., Jiang, W., Luo, X., Driesen, N., Liu, J., Blumberg, H., Tang, Y., Xu, K., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.02.003 · Cited by 84
Hwang, W.-C., Myers, H. F., Chiu, E., Mak, E., Butner, J. E., Fujimoto, K., Wood, J. J., & Miranda, J. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400358 · Cited by 86
Olatunji, B. O., Rosenfield, D., Tart, C. D., Cottraux, J., Powers, M. B., & Smits, J. A. J. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0031865 · Cited by 85
Dold, M., Bartova, L., Fugger, G., Kautzky, A., Souery, D., Mendlewicz, J., Papadimitriou, G. N., Dikeos, D., Ferentinos, P., Porcelli, S., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy009 · Cited by 82
Group treatment for postpartum depression: a systematic review
Goodman, J. H., & Santangelo, G. (2011) · Archives of Women's Mental Health · doi:10.1007/s00737-011-0225-3 · Cited by 74
Friedman, E. S., Davis, L. L., Zisook, S., Wisniewski, S. R., Trivedi, M. H., Fava, M., & Rush, A. J. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.010 · Cited by 81
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Hamilton Rating Scale for Depression (HRSD17) (Hamilton, 1960) was associated with a significantly greater magnitude of symptom reduction; while for patients treated with placebo, a higher initial severity was…”
BackgroundMethodInfluentialBeyazyüz, M., Albayrak, Y., Eğilmez, O. B., Albayrak, N., & Beyazyüz, E. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.2.148 · Cited by 83
Meta-Analysis of the English Version of the Beck Depression Inventory–Second Edition
Erford, B. T., Johnson, E., & Bardoshi, G. (2016) · Measurement and Evaluation in Counseling and Development · doi:10.1177/0748175615596783 · Cited by 85
Gerra, G., Zaimovic, A., Giusti, F., Moi, G., & Brewer, C. (2002) · Addiction Biology · doi:10.1080/1355621021000005973 · Cited by 82
Bright light therapy for depression in Parkinson disease: A randomized controlled trial
Rutten, S., Vriend, C., Smit, J. H., Berendse, H. W., van Someren, E. J. W., Hoogendoorn, A. W., Twisk, J. W. R., van der Werf, Y. D., & van den Heuvel, O. A. (2019) · Neurology · doi:10.1212/wnl.0000000000007090 · Cited by 85
“Unauthorized reproduction of this article is prohibited. at least 1 week of treatment and provided at least 1 postbaseline assessment of the HDRS. Linear mixed-model analyses were used to analyze the effect of the intervention on the different outcome variables.”
MethodInfluentialFlint, A. J., Meyers, B. S., Rothschild, A. J., Whyte, E. M., Alexopoulos, G. S., Rudorfer, M. V., Marino, P., Banerjee, S., Pollari, C. D., Wu, Y., et al. (2019) · JAMA · doi:10.1001/jama.2019.10517 · Cited by 85
Newman, M. G., & Fisher, A. J. (2010) · International Journal of Cognitive Therapy · doi:10.1521/ijct.2010.3.3.245 · Cited by 83
Chen, M.-H., Cheng, C.-M., Gueorguieva, R., Lin, W.-C., Li, C.-T., Hong, C.-J., Tu, P.-C., Bai, Y.-M., Tsai, S.-J., Krystal, J. H., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0480-y · Cited by 84
Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder
Agrawal, M., Richards, W., Beaussant, Y., Shnayder, S., Ameli, R., Roddy, K., Stevens, N., Richards, B., Schor, N., Honstein, H., et al. (2024) · Cancer · doi:10.1002/cncr.35010 · Cited by 88
Redei, E. E., Andrus, B. M., Kwasny, M. J., Seok, J., Cai, X., Ho, J., & Mohr, D. C. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.66 · Cited by 83
Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects
Gorlyn, M., Keilp, J. G., Grunebaum, M. F., Taylor, B. P., Oquendo, M. A., Bruder, G. E., Stewart, J. W., Zalsman, G., & Mann, J. J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0084-x · Cited by 84
“Subjects had a minimum 17-item Hamilton Depression Rating Scale (HDRS) (Hamilton, 1960) score of 16 at time of study entry.”
MethodInfluentialRole of melatonin in mood disorders and the antidepressant effects of agomelatine
Srinivasan, V., De Berardis, D., Shillcutt, S. D., & Brzezinski, A. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.711314 · Cited by 84
Sexual dysfunction associated with antidepressant drugs
Baldwin, D. S. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.5.457 · Cited by 84
Pearson, R., Pisner, D., Meyer, B., Shumake, J., & Beevers, C. G. (2019) · Psychological Medicine · doi:10.1017/s003329171800315x · Cited by 81
“Machine learning was used to predict three treatment outcomes: the Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960), Sheehan Disability Scale (SDS; Sheehan et al ., 1996), and the Well-Being subscale of the Inventory of Depressive Symptoms (IDAS; Watson et al ., 2008).”
MethodAssessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression
Szigeti, B., Weiss, B., Rosas, F. E., Erritzoe, D., Nutt, D., & Carhart-Harris, R. (2024) · Psychological Medicine · doi:10.1017/s0033291723003653 · Cited by 89
“Specifically, on the HAM-D scale, each standard deviation ( ∼ 22 points on the expectancy scale) increase in expectancy is associated with 3.91 points reduction in depression scores, etc. Conversely, in the psilocybin arm, we found no significant interaction between expectancy and timepoint when predicting outcomes on…”
InfluentialImaging the effect of ketamine on synaptic density (SV2A) in the living brain
Holmes, S. E., Finnema, S. J., Naganawa, M., DellaGioia, N., Holden, D., Fowles, K., Davis, M., Ropchan, J., Emory, P., Ye, Y., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01465-2 · Cited by 78
“The HAMD-17 [46], MADRS [47], and BDI [48] were used to assess participants’ mood at screening, at baseline scan, immediately after ketamine infusion, and 24 h after ketamine administration (as well as 1 week and 1 month post-ketamine for clinical participants).”
Method
Metadata
- Authors
- Hamilton, M.
- Affiliations
- University of Leeds (GB)
- Corresponding author
- Hamilton, M.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1960-02-01
- Volume
- 23
- Issue
- 1
- Pages
- 56-62
- ISSN
- 0022-3050 (ISSN-L)
- PMC
- PMC495331
- OpenAlex
- W2114613490
- Semantic Scholar
- b292a2f25e64c16d40374236c95475d44a2c0bd1
- Cited by
- 32,817
- References
- 2
- Citations by year
- 2026: 1044 · 2025: 1239 · 2024: 1266 · 2023: 1197 · 2022: 1212 · 2021: 1286 · 2020: 1248 · 2019: 1096 · 2018: 1125 · 2017: 1043 · 2016: 1124 · 2015: 1146 · 2014: 1189 · 2013: 1172 · 2012: 1038
- FWCI
- 20.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, rating scales, depression assessment, psychometric assessment
- MeSH terms
- Aged, Depression, Depressive Disorder, Humans, Psychometrics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review